Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Net Sales	$ 2,001.4	$ 1,824.2	$ 5,987.7	$ 5,655.4
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 559.3	$ 538.6	$ 1,701.3	$ 1,604.5
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 176.5	$ 148.2	$ 488.2	$ 434.3
Research and development	115.9	111.6	339.8	328.9
Selling, general and administrative	811.4	709.7	2,384.9	2,182.9
Restructuring and other cost reduction initiatives	21.4	32.2	74.9	198.1
Acquisition, integration, divestiture and related	(34.4)	4.4	55.0	9.9
Operating expenses	1,650.1	1,544.7	5,044.1	4,758.6
Operating Profit	351.3	279.5	943.6	896.7
Other income, net	3.3	5.1	10.1	7.0
Interest expense, net	(75.4)	(54.3)	(220.9)	(156.1)
Earnings before income taxes	279.2	230.3	732.8	747.6
Provision (benefit) for income taxes	48.0	(18.9)	165.6	82.5
Net Earnings	231.2	249.2	567.2	665.1
Less: Net earnings attributable to noncontrolling interest	0.3	0.2	1.4	0.8
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 230.9	$ 249.1	$ 565.8	$ 664.3
Earnings Per Common Share
Basic	$ 1.17	$ 1.23	$ 2.85	$ 3.25
Diluted	$ 1.16	$ 1.23	$ 2.84	$ 3.24
Weighted Average Common Shares Outstanding
Basic	198.1	202.3	198.3	204.4
Diluted	198.8	203.0	199.0	205.2